This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Anthem Biosciences Pvt Ltd. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Ravindra Chandrappa Koramangala
Introduction
Ravindra Chandrappa Koramangala is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals through his innovative research and development efforts. His work focuses on the synthesis of novel compounds that have potential applications in various medical fields.
Latest Patents
Ravindra holds a patent for "Compounds of 3-(5-substituted Oxy-2, 4-dinitrophenyl)-2-oxo-propionic acid ester, synthesis and applications thereof." This patent describes the synthesis of the novel compound 3-(5-substituted Oxy-2,4-dinitro-phenyl)-2-oxo-propionic acid ester to produce Pyrroloquinoline quinone (PQQ). The innovative method outlined in the patent allows for a more efficient synthesis of PQQ, resulting in a shorter process and higher yield. Additionally, the patent presents a unique process for creating the sodium compound of PQQ using sodium hydroxide and/or sodium carbonate.
Career Highlights
Ravindra is currently employed at Anthem Biosciences Pvt Ltd, where he continues to advance his research in the pharmaceutical sector. His work has garnered attention for its potential impact on drug development and therapeutic applications.
Collaborations
Ravindra collaborates with talented professionals in his field, including Tom Thomas Puthiaparampil and Ganesh Sambasivam. Their combined expertise contributes to the innovative projects at Anthem Biosciences.
Conclusion
Ravindra Chandrappa Koramangala is a distinguished inventor whose work in synthesizing novel compounds has the potential to revolutionize pharmaceutical applications. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile